Supremex Shine Steels Ltd

Aerpace Industries Ltd announced that its Board of Directors has approved a Scheme of Amalgamation between Aerpace Robotics Private Limited and the Company. This scheme is subject to regulatory and shareholder approvals. Additionally, the Board approved the grant of 500,000 Restricted Stock Units (RSUs) to a Non-Executive Director and the allotment of 865,322 equity shares to employees upon exercise of RSUs. This allotment increases the company's paid-up equity share capital. The amalgamation aims to simplify the group structure, integrate technologies, and create a comprehensive player in next-generation aviation and mobility solutions.

Aerpace Industries Limited announced that its Board of Directors, in a meeting held on October 19, 2026, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board also approved a variation in the objects of a Preferential Issue and re-allocation of unutilized proceeds. This involves re-allocating ₹30.00 crores from the balance consideration receivable upon warrant conversion. Of this, ₹15.00 crores will be for Capital Expenditure and ₹15.00 crores for repayment of loans. The remaining balance will be used for original objects. The company had previously allotted 1,50,00,000 convertible warrants on September 26, 2026, at ₹332.55 per warrant, aggregating to ₹48,82,50,000. A sum of ₹7,50,00,000 was utilized for mobilization advances.

Aerpace Industries' consolidated revenue from operations was nil for a fourth straight quarter, with the only income being ₹0.23 Cr of other income, while total expenses rose to ₹6.15 Cr — widening the consolidated net loss to ₹5.89 Cr (EPS -₹0.38), 71% deeper than the ₹3.45 Cr loss a year ago (Q2 FY26) and 42% worse than the ₹4.15 Cr loss in Q1 FY27. Standalone (parent-only) tells a sharper version of the same story: the loss nearly tripled YoY to ₹5.51 Cr from ₹1.90 Cr, as parent-level total expenses grew 133% YoY to ₹6.72 Cr versus a 74% YoY rise in consolidated expenses (₹6.15 Cr) — the gap indicates cost growth is concentrated at the standalone entity rather than in the Supercars/Dubai subsidiaries, a divergence worth flagging since readers will see both numbers. With core revenue still nil, conventional NPM/OPM are not meaningful (both sit near -100%, matching our own comparison records for the prior two quarters); the loss is being driven purely by the cost base building ahead of revenue — consolidated employee benefit expense ₹2.42 Cr, finance costs ₹0.50 Cr, depreciation ₹0.93 Cr and other expenses ₹2.31 Cr, versus a combined ₹3.53 Cr a year ago. The company continued capitalising setup costs rather than expensing them: ₹1.77 Cr went into CWIP this quarter (₹2.22 Cr for the half-year) on import/installation of machinery, and Intangible Assets under Development — the R&D/product line for the Superwing, Supercar and Aerdock programme — grew to ₹32.88 Cr from ₹27.67 Cr at FY26-end. There is no analyst coverage or formal management guidance on record for this filing — a micro-cap in transition with no revenue yet on its new "aerpace" vertical — so vsStreet and vsGuidance cannot be assessed; no management press release was available in the context either. Alongside results, the board approved reallocating ₹30 Cr of the ₹36.62 Cr balance warrant-conversion proceeds (from the September 2026 preferential allotment of 1.5 Cr warrants to promoter entity N K Family Private Trust) toward ₹15 Cr capex and ₹15 Cr loan repayment, trimming the pure working-capital use to ₹18.83 Cr. Current borrowings jumped to ₹52.70 Cr from just ₹1.42 Cr at FY26-end, funding that capex and working-capital build. The quarter also saw two new director appointments (September 8 and September 24) and a trading-window closure ahead of results — consistent with a company actively building out governance and leadership as it scales a still pre-revenue business line.

Aerpace Industries Ltd has announced that its Board of Directors will convene on October 19, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026, along with their limited review reports. The company also reiterated that the trading window for designated persons remains closed until 48 hours after the declaration of these results. The outcome of the board meeting will be communicated to the stock exchange subsequently.

N.K. Family Private Trust has acquired 1,50,00,000 warrants in Aerpace Industries Limited on September 26, 2026, via Preferential Allotment. This transaction increases their holding of warrants to 1,50,10,000. The total equity share capital of Aerpace Industries Limited remains 15,38,57,982 shares of Rs. 1/- each, while the diluted share capital stands at 17,56,69,573 shares.

Aerpace Industries Limited has completed the allotment of 1,50,00,000 convertible warrants to N.K. Family Private Trust, a promoter group entity. This preferential allotment was made at a price of ₹32.55 per warrant, aggregating to a total value of ₹48,82,50,000. The company has received an initial payment of ₹12,20,62,500/- for this allotment. This move follows prior approvals from the Board of Directors and shareholders, as previously disclosed on July 09, 2026, and August 08, 2026, respectively. All necessary SEBI disclosures have been made.

Aerpace Industries Limited announced board meeting outcomes on September 24, 2026. The board appointed Mr. Giridhar Aramane as an Additional Non-Executive Director, subject to shareholder approval. Additionally, Mr. Rajesh Bhandari was appointed as a Member of the Advisory Board. The board also accepted the resignation of Mr. Milan Bhupendra Shah as a Non-Executive Director. The meeting was held from 3:30 PM to 4:00 PM.

Aerpace Industries Limited announced board changes on September 24, 2026. Mr. Giridhar Aramane was appointed as an Additional Non-Executive Director, subject to shareholder approval. Mr. Rajesh Bhandari was appointed as a Member of the Advisory Board. The company also noted the resignation of Mr. Milan Bhupendra Shah as a Non-Executive Director, effective the same day. These appointments aim to strengthen the company's governance and advisory capabilities.

Aerpace Industries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. During this period, all designated persons, including promoters, directors, key managerial personnel, and their immediate relatives, are prohibited from trading in the company's shares.

Aerpace Industries Limited announced the appointment of Mr. Madhur Sanjay Jajoo as an Additional Director in the category of Non-Executive Independent Director. The appointment was approved by the Board of Directors at a meeting held on September 8, 2026, and is effective from September 9, 2026, for a term of five years, concluding on September 8, 2031. This appointment is subject to shareholder approval. Mr. Jajoo is a Chartered Accountant with approximately six years of professional experience in accounting, financial governance, internal audit, and management consultancy, with expertise in healthcare and oil & gas sectors. He is not related to any existing directors and is not debarred from holding a directorship.